Lipid emulsion form compositions have been formulated and presented to eliminate adverse injection site reactions associated with the intravenous administration of certain sparingly water soluble, hydrophobic, ionizable drugs in mammals and to provide a solubilized drug form for oral, parenteral or intraarticular administration which enhances drug absorption and the therapeutic efficacy of the drug.
脂质乳剂形式组合物的配制和提出,是为了消除与哺乳动物静脉注射某些稀
水溶性、疏
水性、可离子化药物有关的注射部位不良反应,并提供一种用于口服、肠外或关节内给药的溶解药物形式,以促进药物的吸收和疗效。